The Norwegian Institute of Public Health would like to procure diphtheria, tetanus, whooping cough, polio, Haemophilus influenza type B, and hepatitis B combination vaccines (hexavalent vaccine) for babies in the Norwegian child vaccination programme. The procurement is carried out on behalf of the Ministry of Health and Care Services (HOD).
The contest is being held electronically in the CTM KGV and information given in the tender management tool, in the notice, and the tender documentation stipulates the rules and terms for the contest.
NIPH aims to award a contract to one tenderer for a contract period of 2+1+1 years, calculated from 01.01.2024, with the last two years being option years. NIPH would like the first delivery at the latest by the end of the 1st quarter of 2024.
The Norwegian Institute of Public Health would like to procure diphtheria, tetanus, whooping cough, polio, Haemophilus influenza type B, and hepatitis B combination vaccines (hexavalent vaccine) for babies in the Norwegian child vaccination programme. The procurement is carried out on behalf of the Ministry of Health and Care Services (HOD).
The contest is being held electronically in the CTM KGV and information given in the tender management tool, in the notice, and the tender documentation stipulates the rules and terms for the contest.
NIPH aims to award a contract to one tenderer for a contract period of 2+1+1 years, calculated from 01.01.2024, with the last two years being option years. NIPH would like the first delivery at the latest by the end of the 1st quarter of 2024.
The procurement consists of delivery of a hexavalent vaccine (ATC code: J07C A09) for vaccinating babies in the Norwegian child vaccination programme.
The following estimates for the annual number of doses that NIPH needs is based on a year made up of approx. 60,000 persons, and 3 doses are to be given to each person in order to achieve sufficient protection from the diseases.
The estimated annual vaccine requirement will be approx. 180,000 doses (per calendar year).
The estimated maximum scope for the contract period, with the full extension of the contract period (option), is estimated to be approx. 720,000 doses.
The Norwegian Institute of Public Health draws attention to the fact that this is only an estimate and the contracting authority is not bound by the estimated volume.
The Norwegian Institute of Public Health will, in accordance with the contract, procure a minimum volume 160,000 doses per calendar year in the contract period. (Supply agreement point 3.2).
Beyond the minimum volume, the volume that the Norwegian Public Health Authority will eventually order, will depend on demand.
The Norwegian Public Health Institute is not obligated to submit orders beyond the minimum requirement.